Inventor · disambiguated record
Diego Gianolio
Also filed as: GIANOLIO DIEGO · GIANOLIO DIEGO A
8 granted patents·3 pending applications·72 citations·filing 2003–2024
89Inventor score
Top patents by PatentIndex Score
11 records- 0196US11130816B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2019·Granted Sep 28, 2021·6 cites·20 claims
- 0295US12110338B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2021·Granted Oct 8, 2024·2 cites·29 claims
- 0395US11807690B2Hyperglycosylated binding polypeptidesGENZYME CORP·Filed 2019·Granted Nov 7, 2023·4 cites·17 claims
- 0494US10494439B2Hyperglycosylated binding polypeptidesGENZYME CORP·Filed 2017·Granted Dec 3, 2019·9 cites·19 claims
- 0594US9701753B2Hyperglycosylated binding polypeptidesGENZYME CORP·Filed 2014·Granted Jul 11, 2017·16 cites·25 claims
- 0694US9580511B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2014·Granted Feb 28, 2017·17 cites·47 claims
- 0793US10214589B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2017·Granted Feb 26, 2019·9 cites·18 claims
- 0890US2025066497A1Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2024·Application pending·0 cites
- 0988US2024182595A1Hyperglycosylated binding polypeptidesGENZYME CORP·Filed 2023·Application pending·0 cites
- 1061US7387836B2Aziridine compounds and their use in medical devicesGENZYME CORP·Filed 2003·Granted Jun 17, 2008·9 cites·52 claims
- 1141US2005222081A1Cross-linked hyaluronate compoundsGIANOLIO DIEGO A·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →